UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 75

Sortiert nach

A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer

Cancer, 2019-09, Vol.125 (18), p.3184-3197

2019

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 reinfection after previous infection and vaccine breakthrough infection through the second wave of pandemic in India: An observational study

International journal of infectious diseases, 2022-05, Vol.118, p.95-103

2022

Link zum Volltext

Verfügbarkeit prüfen

Long term outcomes of phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early failure oral cancer

The Lancet regional health. Southeast Asia, 2023-05, Vol.12, p.100143-100143, Article 100143

2023

Link zum Volltext

Verfügbarkeit prüfen

Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial

The Lancet global health, 2020-09, Vol.8 (9), p.e1213-e1222

2020

Link zum Volltext

Verfügbarkeit prüfen

Audit of screen failure in 15 randomised studies from a low and middle-income country

Ecancermedicalscience, 2022, Vol.16, p.1476-1476

2022

Link zum Volltext

Verfügbarkeit prüfen

Diclofenac versus tramadol for mucositis related pain in head and neck cancer patients undergoing concurrent chemoradiation-a phase 3 study

Ecancermedicalscience, 2021-11, Vol.15, p.1318

2021

Link zum Volltext

Verfügbarkeit prüfen

Long-term survival outcomes of technically unresectable carcinoma maxilla postinduction chemotherapy

South Asian journal of cancer, 2018-07, Vol.7 (3), p.213-214

2018

Link zum Volltext

Verfügbarkeit prüfen

Authors' reply to Kies and Katna et al

Cancer research, statistics, and treatment (Online), 2020-01, Vol.3 (3), p.653-653

2020

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant Chemotherapy in Locally Advanced and Borderline Resectable Nonsquamous Sinonasal Tumors (Esthesioneuroblastoma and Sinonasal Tumor with Neuroendocrine Differentiation)

International Journal of Surgical Oncology, 2016-01, Vol.2016, p.6923730-8

2016

Link zum Volltext

Verfügbarkeit prüfen

Expectations and preferences for palliative chemotherapy in head and neck cancers patients

Oral oncology, 2016-12, Vol.63, p.10-15

2016

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant chemotherapy in technically unresectable adenocarcinoma of parotid

South Asian journal of cancer, 2019-07, Vol.8 (3), p.185-188

2019

Link zum Volltext

Verfügbarkeit prüfen

Quality of life and quality-adjusted time without toxicity in palliatively treated head-and-neck cancer patients

South Asian journal of cancer, 2018-10, Vol.7 (4), p.249-252

2018

Link zum Volltext

Verfügbarkeit prüfen

Induction chemotherapy in recurrent, unresectable esthesioneuroblastoma

Cancer research, statistics, and treatment (Online), 2018-01, Vol.1 (2), p.171-172

2018

Link zum Volltext

Verfügbarkeit prüfen

Palliative chemotherapy in carcinoma nasopharynx

South Asian journal of cancer, 2019-07, Vol.8 (3), p.173-177

2019

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 vaccine-related skin rash : A case report

Cancer research, statistics, and treatment (Online), 2021-07, Vol.4 (3), p.555-556

2021

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcomes of locally advanced and borderline resectable esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation treated with neoadjuvant chemotherapy

Cancer research, statistics, and treatment (Online), 2020-01, Vol.3 (2), p.201-206

2020

Link zum Volltext

Verfügbarkeit prüfen

A tertiary care experience with paclitaxel and cetuximab as palliative chemotherapy in platinum sensitive and nonsensitive in head and neck cancers

South Asian journal of cancer, 2017-01, Vol.6 (1), p.011-014

2017

Link zum Volltext

Verfügbarkeit prüfen

Palliative oral triple metronomic chemotherapy in a patient with head-and-neck cancer during the COVID-19 pandemic in India: A case report

Cancer research, statistics, and treatment (Online), 2020-01, Vol.3 (3), p.608-609

2020

Link zum Volltext

Verfügbarkeit prüfen

Metronomic palliative chemotherapy in maxillary sinus tumor

South Asian journal of cancer, 2016-04, Vol.5 (2), p.056-058

2016

Link zum Volltext

Verfügbarkeit prüfen

Quality of life without toxicity or symptoms analysis of a randomized controlled clinical trial comparing efficacy of cabazitaxel versus docetaxel in recurrent head and neck cancer

Cancer research, statistics, and treatment (Online), 2018-01, Vol.1 (1), p.46-50

2018

Link zum Volltext

Verfügbarkeit prüfen

Extra-lymphatic filariasis at reconstructive surgery flap site recurrence of head and neck cancer

IDCases, 2016-01, Vol.3 (C), p.8-9

2016

Link zum Volltext

Verfügbarkeit prüfen

Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study

Journal of clinical oncology, 2023-01, Vol.41 (2), p.222-232

2023

Link zum Volltext

Verfügbarkeit prüfen

Outcome of neoadjuvant chemotherapy (NACT) with paclitaxel plus carboplatin and oral metronomic chemotherapy (OMCT) in patients with technically unresectable oral cavity squamous cell carcinoma (SCC)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e18034-e18034

2021

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcomes of a randomized controlled clinical trial comparing the efficacy of cabazitaxel versus docetaxel as second-line or above therapy in recurrent head and neck cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e18008-e18008

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(75)

Publikationsform

Sprache

Englisch
(75)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Life Sciences & Biomedicine
(37)
Oncology
(30)
Humans
(17)
Chemotherapy
(15)
Adult
(14)
Head And Neck Cancer
(13)
Male
(12)
Female
(11)
Middle Aged
(10)
Cancer
(9)
Care And Treatment
(9)
Dentistry, Oral Surgery & Medicine
(9)
Head And Neck Neoplasms - Drug Therapy
(8)
Methods
(8)
Aged
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)
Cancer Research
(5)
Carcinoma, Squamous Cell - Drug Therapy
(5)
Neoadjuvant Chemotherapy
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer

SARS-CoV-2 reinfection after previous infection and vaccine breakthrough infection through the second wave of pandemic in India: An observational study

RMAC study: A randomized study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation

Long term outcomes of phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early failure oral cancer

Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial

Audit of screen failure in 15 randomised studies from a low and middle-income country

Diclofenac versus tramadol for mucositis related pain in head and neck cancer patients undergoing concurrent chemoradiation-a phase 3 study

Long-term survival outcomes of technically unresectable carcinoma maxilla postinduction chemotherapy

Authors' reply to Kies and Katna et al

Neoadjuvant Chemotherapy in Locally Advanced and Borderline Resectable Nonsquamous Sinonasal Tumors (Esthesioneuroblastoma and Sinonasal Tumor with Neuroendocrine Differentiation)

Expectations and preferences for palliative chemotherapy in head and neck cancers patients

Neoadjuvant chemotherapy in technically unresectable adenocarcinoma of parotid

Quality of life and quality-adjusted time without toxicity in palliatively treated head-and-neck cancer patients

Induction chemotherapy in recurrent, unresectable esthesioneuroblastoma

Palliative chemotherapy in carcinoma nasopharynx

COVID-19 vaccine-related skin rash : A case report

Long-term outcomes of locally advanced and borderline resectable esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation treated with neoadjuvant chemotherapy

A tertiary care experience with paclitaxel and cetuximab as palliative chemotherapy in platinum sensitive and nonsensitive in head and neck cancers

Palliative oral triple metronomic chemotherapy in a patient with head-and-neck cancer during the COVID-19 pandemic in India: A case report

Metronomic palliative chemotherapy in maxillary sinus tumor

Quality of life without toxicity or symptoms analysis of a randomized controlled clinical trial comparing efficacy of cabazitaxel versus docetaxel in recurrent head and neck cancer

Extra-lymphatic filariasis at reconstructive surgery flap site recurrence of head and neck cancer

Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study

Outcome of neoadjuvant chemotherapy (NACT) with paclitaxel plus carboplatin and oral metronomic chemotherapy (OMCT) in patients with technically unresectable oral cavity squamous cell carcinoma (SCC)

Long-term outcomes of a randomized controlled clinical trial comparing the efficacy of cabazitaxel versus docetaxel as second-line or above therapy in recurrent head and neck cancer

Suchergebnisse filtern